Michael Hiltzik: Moderna's founders are now billionaires, but where are the doses for the rest of the world?
Let's raise a glass of congratulations to Noubar Afeyan, Robert Langer and Timothy Springer, three newly minted members of the Forbes magazine billionaires roster.
The trio owe their new wealth to the pandemic. More specifically, to the biotech company Moderna's achievement in developing and marketing one of the most efficacious vaccines for COVID-19.
Venture investor Afeyan, Moderna's chairman, is now worth $4 billion by Forbes' reckoning, based on the company's share price; MIT bioengineer Langer, a Moderna co-founder, is worth $3.9 billion; and Harvard biocehmist Springer, an early Moderna investor and owner of 3.5% of the company, is worth $4.8 billion.
They join Moderna CEO StĂŠphan Bancel on the Forbes list, where he landed last year. He's now worth $10.7 billion.
With the praise out of the way, let's now
You’re reading a preview, subscribe to read more.
Start your free 30 days